Search

Search Constraints

You searched for: Author/Creator Yang, James C.-H.

Search Results

1. Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors. (January 2020)

2. Efficacy of alectinib in central nervous system metastases in crizotinib-resistant ALK-positive non–small-cell lung cancer: Comparison of RECIST 1.1 and RANO-HGG criteria. (September 2017)

3. Impact of subsequent immune checkpoint inhibitor treatment on overall survival with avelumab vs docetaxel in platinum-treated advanced NSCLC: Post hoc analyses from the phase 3 JAVELIN Lung 200 trial. (April 2021)

4. Sequencing of therapy following first-line afatinib in patients with EGFR mutation-positive non-small cell lung cancer. (June 2019)